BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18926952)

  • 1. Anti-metastatic action of non-steroidal anti-inflammatory drugs.
    Hung WC
    Kaohsiung J Med Sci; 2008 Aug; 24(8):392-7. PubMed ID: 18926952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives.
    Dermond O; Rüegg C
    Drug Resist Updat; 2001 Oct; 4(5):314-21. PubMed ID: 11991685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
    Tuynman JB; Peppelenbosch MP; Richel DJ
    Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR; DuBois RN
    J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of COX-2 selective inhibitors for prevention and treatment of cancer.
    Amir M; Agarwal HK
    Pharmazie; 2005 Aug; 60(8):563-70. PubMed ID: 16124396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [COX-2 inhibitor and colon cancer].
    Tsujii M
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1799-805. PubMed ID: 11729471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of COX inhibitors in cancer prevention and therapy.
    Umar A; Viner JL; Anderson WF; Hawk ET
    Am J Clin Oncol; 2003 Aug; 26(4):S48-57. PubMed ID: 12902856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer.
    Pereg D; Lishner M
    J Intern Med; 2005 Aug; 258(2):115-23. PubMed ID: 16018788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS; Derksen E; Gaston K
    J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
    Lee TK; Stupans I
    J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
    Kashfi K; Rigas B
    Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action.
    Husain SS; Szabo IL; Tamawski AS
    Am J Gastroenterol; 2002 Mar; 97(3):542-53. PubMed ID: 11922545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer.
    Levy GN
    FASEB J; 1997 Mar; 11(4):234-47. PubMed ID: 9068612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction.
    Rigas B; Shiff SJ
    Med Hypotheses; 2000 Feb; 54(2):210-5. PubMed ID: 10790755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAIDs and breast cancer: a possible prevention and treatment strategy.
    Agrawal A; Fentiman IS
    Int J Clin Pract; 2008 Mar; 62(3):444-9. PubMed ID: 18194278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.